+91-8668442535

Capsule Endoscopes Diagnostics Market By Application (Polyps Detection, Crohn's Disease Diagnosis, Ulcers Monitoring, Celiac Detection, Tumors Of Small Intestine, Occult Gastrointestinal Bleeding, Diverticulosis Detection), By Usage Area (Hospitals, Ambulatory Centers, Private Clinics) - Growth, Future Prospects, And Competitive Analysis, 2017 -2025

The development of capsule endoscopy in 2001 has given gastroenterologists the opportunity to examine the gastrointestinal tract in a non-invasive manner. Capsule endoscopy is a digital healthcare technology that can be utilized to detect gastrointestinal disorders such as gastroparesis, esophageal disease, gastrointestinal bleeding, and colon-related diseases, followed by Crohn's disease and polyposis syndrome. Capsule endoscopy has revolutionized the diagnosis of various parts of the GI system in a very simple manner. Medical professionals can gain an edge in observing the various parameters of the gastrointestinal tract, such as temperature, pressure, and pH, with the help of capsule endoscopes. Capsule endoscopy is an emerging technology that has huge potential in medical diagnostics. The existing wireless capsule endoscopes do not have the ability to treat pathologies related to the gastrointestinal tract. Realizing this, trials are being conducted to explore the direct delivery of the drug to target pathogens such as ulcers or tumors through capsule endoscopes. A capsule endoscope system consists of a wireless video capsule, a sensor array or a sensor belt, a data recorder, and a workstation with the software.

Although there are options available on the market, such as IntelliCap by Philips Electronics and Entering capsule by Phaeton Research (these systems are capable of delivering up to 1 ml of the drug to a region in the GI tract like the colon, ileum, and jejunum), these systems do not deliver the drug to the target areas like ulcers or tumors. Recently, the FDA approved the first drug, Abilify MyCite, which tracks the ingestion of medication by the patient, and physicians can monitor this activity on their phones. The system includes a sensor that transmits the information to a wearable patch.

This study, titled "Capsule Endoscopes Diagnostics Market: Growth, Future Prospects, and Competitive Analysis, 2017–2025," states a comprehensive analysis offering company executives, investors, industry participants, and developers the opportunity to take strategic initiatives and reach verdicts related to the scenarios in the global capsule endoscopes diagnostics market. This report explains and analyses the major trends in the global capsule endoscopes diagnostics market, as well as provides market size and forecast.

This section of the report comprises segments in the form of diseases of the gastrointestinal tract and their geographical distribution. The segments are further categorized into polyp detection, Crohn's disease diagnosis, ulcer monitoring, celiac detection, tumors of the small intestine, occult gastrointestinal bleeding, diverticulosis detection, and others. Forecast and market size for the aforementioned segments are performed for the period 2015-2025, along with CAGRs for the period 2017-2025.

This report incorporates the geographical distribution into five main regions along with major countries, which are as follows:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • U.K.
    • Russia
    • Rest of Europe
  • Asia-Pacific
    • India
    • China
    • Japan
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East and Africa

The detailed description of the above-mentioned geographical market is covered for the duration of 2015–2025; the report also comprises the CAGRs for the duration of 2017–2025, which are further classified on the basis of usage area and at the country level.

An in-depth analysis is related to the market dynamics, such as drivers, restraints, and opportunities, which is presented in the report and clarifies the current trends in the market. Various tools have been used to demonstrate the competitive landscape and potential value of the market. Company profiling is also done for the major players who hold the strongest positions in the market. Some of the major players in the global capsule endoscope diagnostics market are CapsoVision, Inc., Check-Cap Ltd., Given Imaging Ltd., IntroMedic Co., Ltd., Chongqing Jinshan Science & Technology (Group) Co., Ltd., Olympus Corporation, RF Co., Ltd., Philips Healthcare, Smartpill, Inc., Siemens Healthcare, Stryker Corporation, and more.

The global capsule endoscopes diagnostics market is being studied for its application in the following areas for the purposes of this study:

  • Polyps Detection
  • Diagnosis of Crohn's Disease
  • Ulcers Monitoring
  • Celiac Detection
  • Cancer of the small intestine
  • Occult gastrointestinal bleeding
  • Diverticulosis Detection
  • Others

At present, gastrointestinal diseases are a source of considerable mortality, cost, and morbidity in the United States. According to the National Institute of Diabetes and Digestive and Kidney Disease (NIDDK) statistics, 60–70 million people in the U.S. are affected by gastrointestinal disease annually. According to data from 2004, an estimated 72 million ambulatory center visits, 4.6 million hospitalizations, and 236,000 deaths occurred from gastrointestinal diseases. The market for capsule endoscopes for diagnostic purposes is strongly supported by technological advancement. Growing life expectancy is also one of the main factors that help boost the capsule endoscope diagnostics market.

Since their discovery in the year 2000, capsule endoscopes have served as replacements for traditional endoscopes, providing a non-invasive method of inspecting the gastrointestinal tract. The increase in the prevalence of diseases related to the gastrointestinal tract and digestive system and the growth in demand for non-invasive procedures are boosting the growth of the capsule endoscope diagnostics market. Growing healthcare sectors and technological advancement are the other drivers of this market.

The global capsule endoscopes diagnostics market is being studied for its application in the following usage areas for the purposes of this study:

  • Hospitals
  • Ambulatory Centers
  • Private Clinics

Among the considered research areas, capsule endoscopes enjoy the largest application in hospitals, followed by ambulatory centers. Higher affordability of hospitals in terms of the purchase of capsule endoscopes, the advantage of a minimal or non-invasive procedure, and an increase in the number of patients visiting hospitals for the diagnosis, treatment, and management of GI diseases are the major factors facilitating the adoption of capsule endoscopes in hospitals. It is further expected that due to the increasing preference of patients for approaching specialized private clinics for their requirements due to faster turnaround times and better treatment outcomes, the demand for capsule endoscopes from private clinics will be higher during the forecast period. Additionally, capsule endoscopy is a new introduction in the endoscopy field, and extensive research and study are being performed to boost the application of capsule endoscopes.

The global capsule endoscope diagnostics market is divided into five regions: Europe, Asia Pacific, North America, the Middle East, Africa, and Latin America.

North America and Europe held the largest share of the global capsule endoscope diagnostics market in 2016, followed by Asia Pacific, owing to major driving factors such as the rising prevalence of gastrointestinal diseases and favorable reimbursement policies. According to the estimates of the American Cancer Society, about 50,260 deaths are predicted to be caused in 2017 by colorectal cancer, which is the third leading cause of death in the United States. Because capsule endoscopy is fully secure and non-invasive, serving the growing demand for non-invasive diagnosis procedures is expected to increase in the near future. During the forecast period of 2017–2025, Asia Pacific is estimated to be the fastest-growing region due to key driving factors such as the rising prevalence of GI disease in developing countries, increasing awareness associated with early GI disease diagnosis, developing healthcare infrastructure, and mounting demand for the non-invasive procedure.

The detailed regional classification of the global diabetes drug market is as follows:

  • North America (Canada and the United States)
  • Asia Pacific (India, China, Japan, and the Rest of Asia Pacific)
  • Europe (France, Italy, Germany, the U.K., Spain, and the Rest of Europe)
  • Latin America (Brazil, Mexico, and the Rest of Latin America)
  • Middle East and Africa (GCC plus the rest of the Middle East and Africa) 

Frequently Asked Questions:

The market for Capsule Endoscopes Diagnostics Market is expected to reach US$ 785 Mn By 2025.

The Capsule Endoscopes Diagnostics Market is expected to see significant CAGR growth over the coming years, at 14.45%.

The report is forecasted from 2017-2025.

The base year of this report is 2016.

CapsoVision, Inc., Check-Cap Ltd., Given Imaging Ltd., IntroMedic Co., Ltd., Chongqing Jinshan Science & Technology (Group) Co., Ltd., Olympus Corporation, RF Co., Ltd., Philips Healthcare, Smartpill, Inc., Siemens Healthcare, Stryker Corporationare some of the major players in the global market.

Choose License Type
Trusted By
Godaddy
Published Date:  Nov 2017
Category:  Medical Devices
Report ID:   58838
Report Format:   PDF
Pages:   120
Rating:    4.8 (60)
Delivery Time: 24 Hours to 48 Hours   
Connect With Us
+91-8668442535
24/7 Research Support